A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
|2||Active, not recruiting||
PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery
† Study has passed its completion date and status has not been verified in more than two years.